Elara Capital Initiates 'Buy' Rating on Sagility, Predicts 26% Upside
Elara initiates on Sagility with Buy; sees long growth runway, 26% upside
Business Standard
Image: Business Standard
Elara Capital has initiated coverage on Sagility, a healthcare technology provider, with a 'Buy' rating, projecting a 26% upside from its current price. The firm anticipates revenue and earnings growth driven by increased outsourcing opportunities amid rising medical loss ratios and administrative costs for payers.
- 01Elara Capital projects Sagility's revenue and earnings to grow at 13.9% and 20% CAGR, respectively, over FY26E–FY28E.
- 02The target price for Sagility is set at ₹54, indicating a potential upside of 26% from its recent trading level.
- 03Sagility's revenue from its top five clients is expected to increase significantly, with potential for 80-90% growth.
- 04Rising medical loss ratios among payers are creating more outsourcing opportunities for Sagility.
- 05Analysts flag potential risks, including a decline in medical loss ratios that could impact outsourcing demand.
Advertisement
In-Article Ad
Elara Capital has initiated coverage on Sagility, a healthcare-focused technology provider, with a 'Buy' rating, citing a projected 26% upside from its current trading price of ₹42.28. The brokerage expects Sagility to achieve revenue and earnings compound annual growth rates (CAGRs) of 13.9% and 20%, respectively, over the fiscal years 2026 to 2028. Elara has set a target price of ₹54, valuing the company at 19 times its expected earnings per share for FY28. Sagility's revenue is heavily reliant on its top clients, with 60% of revenue coming from its top three clients alone. Analysts believe there is significant growth potential, particularly as medical loss ratios rise among major payers, creating more outsourcing opportunities. Despite some concerns regarding client concentration, Elara Capital views the potential for earnings growth as strong, with a projected 20% CAGR over the same period. However, they caution that any decrease in medical loss ratios could negatively impact demand for outsourcing services.
Advertisement
In-Article Ad
Sagility's growth could lead to increased job opportunities and enhanced services in the healthcare technology sector, benefiting clients and employees alike.
Advertisement
In-Article Ad
Reader Poll
Do you think Sagility will achieve its projected growth targets?
Connecting to poll...
More about Elara Capital
Read the original article
Visit the source for the complete story.